Vietnam facing worsening African swine fever outbreaks
The country has detected 972 African swine fever outbreaks so far this year, up from 514 reported in mid-July, the Tien Phong newspaper reported.
The number of pigs infected has risen to more than 100,000 from 30,000 over the same period, the paper said, citing Vietnam's agriculture ministry. The infected pigs have died or been culled.
'ASF has broken out on a very large scale, spreading across the country, seriously affecting the livestock industry, especially the supply of pork,' Nguyen Xuan Duong, chairman of the Animal Husbandry Association of Vietnam, was quoted as saying. He added that no province is safe from the disease.
African swine fever has disrupted the global pork market for years. In the worst outbreak over 2018-19, about half the domestic pig population died in China, the world's biggest producer, causing losses estimated at over $100 billion.
The outbreaks in Vietnam last month prompted Prime Minister Pham Minh Chinh to send an urgent directive to provinces and government agencies to deploy measures to curb the disease, which the government said was threatening to disrupt food supplies.
Though Vietnam was the first country reportedly to have developed an African swine fever vaccine that has been in commercial use since 2023, officials said the vaccination rate was low due to concerns about costs and efficiency.
'Vaccination is just a supporting tool that can not replace basic prevention measures,' Duong said.
AVAC Vietnam JSC, the country's main African swine fever vaccine producer, didn't respond to Reuters' request for comment.
AVAC said in June it had sold 3 million vaccine doses in the domestic market and exported 600,000 doses to other countries, including the Philippines and Indonesia.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Al Arabiya
3 days ago
- Al Arabiya
Thai Princess, in hospital since 2022, treated for blood infection: Palace
Thailand's Princess Bajrakitiyabha Narendira Debyavati developed a severe bloodstream infection and remains under medical care, the royal palace said on Friday in its first announcement about her condition since 2023. The 46-year-old princess, the oldest child of King Maha Vajiralongkorn, was hospitalized in December 2022 after losing consciousness as a result of a heart condition, the palace said in a statement. The palace said medication and equipment were being used to support her lung and kidney function. Last week, a medical team administered antibiotics after detecting a severe infection in her bloodstream. Blood pressure medication was also administered, the palace said.
Arab News
5 days ago
- Arab News
Study reveals genetic insights about Saudi and Japanese populations
RIYADH: A new study using Saudi and Japanese pangenome samples exclusively has revealed genetic insights relating to these two populations. 'Up to 12 percent of patients with genetic disorders go undiagnosed due to reliance on reference genomes that don't reflect their population's genetic background,' said Malak Abedalthagafi, professor at Tufts Medical Center and one of the lead authors of the study. 'By constructing population-specific pangenome graphs, we improve variant calling and help close this diagnostic gap.' The pangenome is considered a powerful reference tool to study individual and group DNA. Similar to how a map shows a person's position in relation to their landscape, the pangenome allows researchers to compare a person's genetic makeup with the full spectrum of genetic variation found across a population. 'Having worked on the Saudi genome for several years, contributing to this project marks a meaningful step in my commitment to advancing representation in genomics and ensuring precision medicine serves diverse populations,' Abedalthagafi said. Fellow author of the study and KAUST Professor Robert Hoehndorf explained that building the graphs, which the study calls JaSaPaGe (Japanese Saudi PanGenome), using samples from two distinctive populations offers new health insights. 'Japan and Saudi Arabia are pretty much at the opposite ends of Asia and have been separated for a long time. It gave us a chance to study the effects of population-specific pangenome graphs on variant calling when populations do not match,' Hoehndorf said. JIHS' Yosuke Kawai, another author of the study, added that there were clinical benefits to be gained for both populations. He said: 'The joint development of a population-specific pangenome graph for the Japanese and Saudi Arabian populations addresses a critical gap in global genomic representation. 'By integrating diverse data from both countries, we have created a powerful resource that not only improves variant detection accuracy but also holds great potential for advancing precision medicine tailored to each population's unique genetic landscape.' The first human pangenome was reported in 2023, but none of the DNA samples collected were taken from individuals with Arab or Japanese descent, meaning it was constructed without representation from almost 10 percent of the world's population. The study was carried out by King Abdullah University of Science and Technology, Tufts University and the Japan Institute for Health Security.
Arab News
6 days ago
- Arab News
WHO says training 49,000 health workers for Pakistan's first HPV vaccination drive in September
KARACHI: The World Health Organization (WHO) said on Tuesday it is partnering with the Pakistani government to train 49,000 health workers for the country's first human papillomavirus (HPV) vaccination drive from Sept. 15-27, highlighting that it would target 13 million girls and help protect them from cervical cancer. HPV is a very common virus that can cause cancers later in life, according to the Centers for Disease Control and Prevention (CDC). About 13 million people, including teens, become infected with HPV each year. Medical experts recommend protecting children from these cancers through the HPV vaccine. In its press release, the WHO said cervical cancer ranks as the third most frequent cancer among Pakistani women. It said the country has a female population of 73.8 million aged 15 years and older at risk of the virus and reports 5,000 new cases of cervical cancer in women annually. The global health body said almost 3,200 of these 5,000 cases, roughly 64 percent, die from the disease. 'The campaign will be a historic milestone to prevent cervical cancer in the country, targeting for the first time 13 million girls aged 9 to 14 years across Punjab, Sindh, Islamabad Capital Territory and Pakistan-administered Kashmir,' the statement said. The WHO said that with funding support from Gavi, the Vaccine Alliance, the training sessions for health workers will be conducted until the end of August and would focus on microplanning and essential skills for vaccinators, doctors, social mobilizers and data entry operators. It said WHO's support for the drive includes technical guidance for conceptualization, planning, data analysis, readiness assessments and capacity development in close collaboration with partners, the Pakistan Federal Directorate of Immunization (FDI) and its Expanded Programme on Immunization (EPI) at the federal and provincial levels. 'This HPV vaccination campaign is more than just a public health intervention; it is an investment in the health and potential of our daughters,' Dr. Soofia Yunus, director-general, FDI, said. 'By embracing this vaccine, Pakistan is taking a big step to protect its future from cervical cancer.' It said the vaccination campaign aligns with the World Health Assembly's Global Strategy for cervical cancer elimination. The strategy aims that by 2030, 90 percent of girls are fully vaccinated with the HPV vaccine by 15 years of age, 70 percent of women are screened, and 90 percent of women with pre-cancer or invasive cancer receive treatment. The global health body said Pakistan's mortality rate for cervical cancer can primarily be attributed to delayed diagnoses and limited access to screening programs. The WHO said a recent study it conducted across 18 health care facilities in Pakistan from 2021-2023, 1,580 cases of cervical cancer were documented, indicating a significant underestimation of the disease burden due to low screening rates and the lack of a national cervical cancer registry. 'Modelling data indicates that, in the absence of vaccination, the cervical cancer disease burden in Pakistan will increase markedly by at least three-fold over the next seven decades,' the statement said. WHO said the HPV vaccine's phased introduction will pave the way for its eventual rollout in other Pakistani provinces and areas, such as the northwestern Khyber Pakhtunkhwa in 2026, and Balochistan and Gilgit-Baltistan in 2027.
